Adenomas hipofisarios no funcionales: Revisión de la literatura
DOI:
https://doi.org/10.18041/1900-7841/rcslibre.2019v14n2.7269Palabras clave:
Adenoma hipofisario no funcionante, Incidentaloma hipofisario, Cirugía hipofisaria, Defecto campo visualResumen
Los Adenomas Hipofisarios no Funcionales (AHNF) es el término utilizado para describir los tumores hipofisarios que no presentan algún tipo de secreción hormonal que provoque síntomas de hiperfunción, representan entre el 15 y el 30% de todos los tumores hipofisarios, tienen una frecuencia similar en ambos sexos y una presentación algo más frecuente en la quinta década de la vida. En cuanto a su presentación clínica generalmente lo hacen como macroadenomas (al menos el 60%) que causan síntomas compresivos, en el restante se encuentran escasas o nulas manifestaciones sintomáticas dada su no funcionalidad hormonal. El diagnóstico también se podría generar en el contexto de un incidentaloma hipofisario. El tratamiento de elección es la microcirugía hipofisaria transesfenoidal ante la presencia de macrotumores mayores de 1 cm o bien aquellos de elección en pacientes con alteración visual; el seguimiento postoperatorio es importante para diagnosticar los déficits hormonales subsecuentes e identificar posibles recidivas.
Descargas
Referencias
Alexander JM, Biller BM, et all. A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 1990;86:336-40.
Ambrosi B, Colombo P, et all. The silent corticotropinoma: is clinical diagnosis possible. J Endocrinol Invest 1992; 15:443-452.
Mercado M, Melgar V, et all. Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects. Endocrinol Diabetes Nutr. 2017;64(7):384-395
Campero A. Macroadenomas de hipófisis con extensión supraselar: resultados quirúrgicos en 26 casos operados por vía endonasal transesfenoidal. Rev Arg Neurocir 2007;21: 15-22.
Chanson P, Young J. Pituitary incidentalomas. Endocrinologist. 2003;13:124-135.
Dekkers OM, Pereira AM, et all.Treatment and followup of clinically non functioning pituitary macroadenomas. J Clin Endocrinol Metab. 2008; 93: 3717-3726.
Lim CT, Korbonits M. Update on the clinicopathology of pituitary adenomas. Endocr Pract. 2018;24(5):473-488.
Pérez-López C, Palpán AJ, et all. Adenomas hipofisarios no funcionantes: epidemiología, clínica y evolución posquirúrgica, Rev Neurol. 2020;71 (05):163-170
Raapana A, Koivukangas J,et all. Incidence of pituitary adenomas in Northern Finland in 1992-2007.J Clin Endocrinol Metab. 2010; 95(9): 4268-4275.
Fernandez A, Karavitaki N, et all. Prevalence of pituitary adenomas: a community-based cross-sectional strudy in Branbury. Clin Endocrinol (Oxf). 2010; 72: 377-382.
Batista RL, Trarbach EB, et all. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile. World Neurosurg. 2018;120:241-246.
Kinoshita Y, Kurisu K, et all. Nonfunctioning pituitary adenomas in elderly patients. J Clin Neurosci. 2018;53:127-131.
Iglesias P, Rodríguez Berrocal V,et all. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine. 2018;61(3):407-421.
Donovan L.E, Corenblun B. The natural history of the pituitary incidentaloma. Arch Intern Med. 1995; 155: 181-183.
Esquenazi Y, Guinto G, et all. El incidentaloma hipofisario. Gac Méd Méx. 2008; 144(1): 47-53.
Galland F, Vantyghem MC, et al. Management of nonfunctioning pituitary incidentaloma. Ann Endocrinol. 2015;76(3):191-200.
Gilzanz A, Moreno B, et all. Guía clínica del diagnóstico y tratamiento de los tumores hipofisarios no funcionantes y gonadotropinomas. Endocrinol Nutr. 2006; 53(1): 13-18.
Orija IB, Weil RJ, et all. Pituitary incidentaloma. Best Pract Res Clin Endocrinol Metab. 2012; 26(1):47-68
Freda P.U, Kalmon D. Differential diagnosis of sellar masses. Endocrinology Metabolism Clinics of North America 1999; 28(1):81-117.
Vargas G, González B, et al. Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenoma. International Journal of Endocrinology 2015: 756-769.
Freda, P, Beckers, A. M, et all. Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2011 96(4), 894–904.
Rogers A., Karavitaki N, et all. Diagnosis and management of prolactinomas and non-functioning pituitary adenomas. BMJ. 2014: 349; 5390–5390.
Glerean M, Vitale M, et all. Gonadotrofinomas: análisis multicéntrico y retrospectivo de 66 pacientes, Revista Argentina de Endocrinología y Metabolismo 2009: 46(3):3-10.
Olsson DS, Hammarstrand C, et all. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma. Endocr Relat Cancer. 2017;24(5):227-235.
Non Functioning Pituitary Adenomas. In: Feingold KR, Anawalt B, Boyce A. Endotext [Internet]. [consultado el 24 Feb 2021]. Disponible en: http://MDText.com
Greenman Y, Melmed S. Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med. 1996;47:95-106.
Iglesias P. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine. 2016;58(2):307-331.
Gsponer J, De Tribolet N, et al. Diagnosis, treatment,and outcome of pituitary tumors and other abnormal intrasellar masses. Medicine. 1999; 78: 236-269.
Hernández A, Santana F, et all. Adenoma hipofisario no funcionante, aspectos clínicos y terapéuticos. Rev Cubana Endocrinología. 1993; 4(2): 99-107.
Chanson P, Raverot G, et al. Management of clinically non-functioning pituitary adenoma. Annales d’Endocrinologie.2015; 76:239-247.
Husted Nielsen E, Lindholm J, et al. Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clinical Endocrinology 2006; 64: 319-322.
Jaffe C.A. Clinically non-functioning pituitary adenoma. Pituitary. 2006; 9: 317-321.
López-Juárez N, Vargas G, et al. Valor pronóstico de las características clínicas, bioquímicas e imagenológicas en los pacientes con macroadenomas hipofisarios clínicamente no funcionantes al momento del diagnóstico. Revista de Endocrinología y Nutrición. 2009;17(3):115-119.
Molitch ME, Rusell E. The pituitary “incidentaloma”. Ann Intern Med. 1990; 112: 925-931.
Teramoto A, Hirakawa K, et all. Incidental pituitary lesions in 1000 unselected autopsy specimens. Radiology. 1994;193:161-164.
Del Basso De Caro M, Solari D, Pagliuca F, et al. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurgical Review. 2017; 40(1): 105-114.
Zee CS, Go JL, et all. Imaging of the pituitary and parasellar region. Neurosurg Clin N Am. 2003;14:55-80.
Wentworth J.M, Gao N, et all. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement in seldom necessary. Clinical Endocrinology. 2008; 68: 29-35.
Cortet-Rudelli C, Bonneville JF, et al. Post-surgical management of non-functioning pituitary adenoma. Ann Endocrinol. 2015;76(3):228-38
Salvador J, Sopena M. Tumores hipofisarios no funcionantes. Endocrinología. 1996; 43(10): 350-361.
Molitch ME. Diagnosis and treatment of pituitary adenomas. JAMA. 2017; 317(5): 516-524.
Adams JR, Blevins LS Jr,et al. Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution’s experience. Pituitary. 2006; 9:93.
Kristof RA, Rother M, et all. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg. 2009; 111:555.
Zada G, Liu CY, et al. Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg. 2007; 106:66.
Boguszewski CL, de Castro Musolino NR, et all. Management of pituitary incidentaloma. Best Pract Res Clin Endocrinol Metab. 2019;33(2):1012-1068.
Gravdahl GB, Tronvik EA, et all. Pituitary Adenoma and Non-acute Headache: Is There an Association, and Does Treatment Help, World Neurosurg. 2016;92:284-291.
Tampourlou M, Karapanou O, et all. Medical therapy for non-functioning pituitary tumors-a critical approach. Hormones. 2019; 18 (2):117-126.
Kotecha R, Sahgal A, et al. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion. Neuro Oncol. 2020; 5;22(3):318-332.
Delgado-López PD, Pi-Barrio J, et al. Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options. Clin Transl Oncol. 2018;20(10):1233-1245
Taniguchi K, Gomez-Apo E, et al. Molecular alterations in non-functioning pituitary adenomas. Cancer Biomark. 2020;28(2):193-199.
